ABT
Abbott Laboratories
- Depreciation and amortization, 2025
- $3.1B
- YoY, 2025
- −3.2%
- 5-year CAGR
- −1.3%
- 10-year CAGR
- +7.8%
Depreciation and amortization
Depreciation and amortization by fiscal year
| Period | D&A | YoY |
|---|---|---|
| 2025 | $3.1B | −3.2% |
| 2024 | $3.2B | −0.8% |
| 2023 | $3.2B | −0.7% |
| 2022 | $3.3B | −7.7% |
| 2021 | $3.5B | +6.3% |
| 2020 | $3.3B | +10.4% |
| 2019 | $3.0B | −8.1% |
| 2018 | $3.3B | +8.5% |
| 2017 | $3.0B | +123.3% |
| 2016 | $1.4B | −8.1% |
| 2015 | $1.5B | −4.9% |
| 2014 | $1.5B | −9.9% |
| 2013 | $1.7B | −38.2% |
| 2012 | $2.8B | −8.6% |
| 2011 | $3.0B | +16.0% |
| 2010 | $2.6B | +25.6% |
| 2009 | $2.1B | +13.6% |
| 2008 | $1.8B | −0.9% |
| 2007 | $1.9B | — |